9 AI News and Ratings on Wall Street’s Radar

8. iCAD, Inc. (NASDAQ:ICAD)

Number of Hedge Fund Holders: 4

iCAD, Inc. (NASDAQ:ICAD) provides AI-driven cancer detection and therapy solutions, including breast imaging and risk assessment tools, across its Detection and Therapy segments in the U.S.

On February 19, iCAD announced that it will present five studies on AI-powered breast health advancements at the European Congress of Radiology 2025 in Vienna. The studies focus on improving cancer detection, risk assessment, and breast arterial calcification analysis. iCAD will also introduce ProFound Cloud, a secure SaaS platform providing access to its AI solutions for healthcare providers.

Presentations will cover topics such as AI-based risk models, optimizing mammography screening programs, and improving workflow efficiency through AI case scoring. Additionally, a virtual abstract will highlight a new method for developing a breast arterial calcification detection algorithm.